semaglutide and cancer GLP-1s appear to cut risk. Researchers are asking why how : NPR semaglutide cancer cases GLP-1 medications

Lancet Elsevier Ltd

In Marina del Rey, Beauty Innovations has been at the center of this evolving conversation

Explore the top headlines, including results from a first-of-its-kind clinical trial testing the GLP-1 drug semaglutides effect on Alzheimers disease, a novel tau-targeting therapy, and new blood tests (biomarkers) that could help detect Alzheimers earlier

Furthermore, research literature highlights its ability to downregulate matrix metalloproteinases (MMPs) and modulate the expression of antioxidant enzymes

Since these medications slow stomach emptying and reduce hunger signals, food choices become even more important